Manufacturing channel feed – Endpoints News

The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

AstraZeneca cuts UK funding pledge; Viking says it has ‘enough’ API for trials

3 months ago

Updated: Novo Nordisk sees growth slowing this year, plans CagriSema filing for 2026

3 months ago

Bavarian Nordic’s stock sinks after 2024 revenues underwhelm

3 months ago

Charles River to shut down North Carolina pathology facility, says it's not a 'strategic fit'

3 months ago

Thermo Fisher to lay off 300 workers at two viral vector factories

3 months ago

Updated: Drug prices likely to soar due to Trump tariffs, pharma bodies warn

3 months ago

J&J’s Rybrevant gets CHMP backing weeks after FDA rejection

3 months ago

AstraZeneca scraps UK vaccine site expansion after government budget cuts

3 months ago

Celltrion looks to buy US facilities to sidestep potential Trump tariffs

3 months ago

Rentschler exits cell and gene business due to low demand, will prioritize biologics

3 months ago

Bright Green budgets $3.5B for new builds; European Commission opens biomanufacturing hub

3 months ago

Lonza looks to buy facilities and tech to boost service offerings

3 months ago

Semaglutide, tirzepatide compounder hit with FDA warning letter

3 months ago

Lantheus to buy radiopharma CDMO and diagnostic assets for $250M upfront

3 months ago

UK biotech launches with T cell therapy technology to treat solid tumors

3 months ago

Takeda discontinues US supply of gout drug Uloric over generic competition

4 months ago

Catalent to make CAR-T for Galapagos; Kindeva gets $129M for nerve agent antidote

4 months ago

Samsung Bio hits revenue high, secures largest contract to date

4 months ago

Sanofi says no supply interruptions after landing FDA warning letter for US site

4 months ago

Denmark’s new manufacturing learning center; Telix buys facility, assets and tech from ImaginAb

4 months ago

Vaccine patch startup collects an additional $16M to Series A

4 months ago

Samsung Bio eyes construction of sixth manufacturing plant to kickstart 2025

4 months ago

Eli Lilly misses 2024 revenue expectations, stock dips 7%

4 months ago

Charles River disappoints investors with damp outlook for 2025

4 months ago

First page Previous page 2 3 456 7 8 Next page Last page